Patients suffering from T cell mediated autoimmune diseases (AIDs) show immune abnormalities that resemble the typical characteristics of immune dysfunction described in the elderly. In addition, the incidence of AIDs increases with advancing age. To evaluate whether rheumatoid arthritis (RA) and multiple sclerosis (MS) patients have suffered from a premature immunosenescence, we measured two indicators of aging. The number of T cell receptor excision circles (TRECs) and the percentage of CD4+CD28 null T cells were studied in peripheral blood mononuclear cells (PBMC) of 60 RA patients, 32 MS patients and 40
INTRODUCTION
Autoimmune diseases (AIDs) often arise at advanced age. Patients suffering from T cell mediated AIDs show immune abnormalities that resemble the typical characteristics of immune dysfunction described in the elderly. Several groups have observed T cell clonal expansions in the peripheral blood of rheumatoid arthritis (RA) patients. [1] [2] [3] [4] Others have reported a population of T cells in RA patients with signs of replicative stress. [2] [3] [4] [5] [6] An important aspect of immunosenescence is thymic involution. 7 During thymic involution the epithelial space, where T cell maturation and selection takes place, is replaced by fatty tissue. This restructuring process causes a decline in the output of new T cells from the thymus. 7 A space filling auto-proliferation mechanism, known as homeostatic proliferation, keeps peripheral T cell numbers at a constant level throughout life and becomes particularly important with advancing age. 8 However, this mechanism will induce replicative stress on peripheral T cells.
Replicatively stressed cells have lost the expression of the major costimulatory molecule CD28 which is accompanied by some phenotypic and functional changes. [9] [10] [11] [12] Premature aging, associated thymic involution and compensatory auto-proliferation could play an important role in the pathogenesis of autoimmunity. It has been shown in mice that severe T cell depletion or the transfer of small numbers of T cells into T cell deficient hosts induces immunopathology and the development of AIDs. 13, 14 Apparently, the control mechanisms that maintain a stable and diverse repertoire of naïve and memory T cells in a healthy functional immune system are severely compromised in lymphopenic conditions. 15 In addition, lymphopenia induced auto-proliferation causes the accumulation of potential autoaggressive T cells and their functional capacities could confer an increased risk for developing autoimmunity. To evaluate whether the immune system of patients with RA or multiple sclerosis (MS) has undergone premature aging, we measured the number of T cell receptor excision circles (TRECs) and the percentage of CD4+CD28 null T cells in peripheral blood mononuclear cells (PBMC). These parameters are important indicators of aging of the immune system. Cells were analyzed with a FACS Calibur (BD Biosciences). The percentage of CD28 null T cells within the CD4+ T cell population was then calculated.
MATERIALS AND METHODS

Patients and controls
Quantification of TREC numbers
Genomic DNA was isolated by incubating cells in lysis buffer (75 mM NaCl, 25 mM EDTA, 1% sodium dodecyl sulfate (SDS) and 50 µg/ml proteinase K) for 1 hour at 37°C, followed by 
Statistical analysis
Using SPSS software, one-way analysis of variance (ANOVA) was performed to compare 
RESULTS
Premature thymic involution in RA and MS patients
Thymic output can be estimated by evaluating the TREC content in PBMC. TRECs are generated as extrachromosomal by-products during the recombination of V(D)J gene segments of the T cell receptor (TCR). TRECs are stable, do not replicate and are therefore diluted with every cell division. 16 The δRec-ϕJα signal joint (sj) TREC was described to be a good measure for thymic output. 17 Figure 1 shows that TREC numbers declined progressively with age in PBMC of HC, indicating an age-dependent decrease in thymic output.
Remarkably, TREC numbers in the youngest RA patients (15-40 years) were comparable to TREC numbers in the oldest HC (60 years and older) and did not decline further with age. A statistically significant lower number of TRECs was observed in RA patients as compared to HC in the age group of 41 to 60 years ( Figure 1 ). In addition, TREC numbers in MS patients were lower as compared to age-matched healthy individuals, especially in the youngest MS patients. However, these differences were not statistically significant (Figure 1 ). Apparently, during the first decades of life, thymic involution had progressed at a faster rate in RA and MS patients as compared to HC.
Age-independent high frequencies of CD4+CD28 null T cells in RA and MS patients
Studies on human aging have identified the loss of CD28 expression on both CD4+ and CD8+
T cells as the best biological indicator of aging in the immune system. 18 Surprisingly, frequencies of CD4+CD28 null T cells did not increase with advancing age in HC (Figure 2 ). In the youngest age groups, no difference in the percentage of CD4+CD28 null T cells between HC, RA and MS patients could be observed. However, percentages of CD4+CD28 null T cells did increase with advancing age in RA and MS patients. In the oldest age group, RA patients had significantly more CD4+CD28 null T cells compared to age matched HC (Figure 2 proteoglycans, heat shock proteins (HSP)) and MS (myelin components), the disease 'triggering' antigen has not been identified. 20 These findings support the concept that AIDs are not caused by a single autoantigen, but may rather result from a general dysfunction of peripheral immune tolerance or homeostasis mechanisms.
In this study, TREC content and the percentage of CD4+CD28 null T cells were studied as indicators of immunosenescence. Although the sizes of the groups were often too small to obtain significant differences, the observed age-inappropriate low TREC numbers indicate that RA and MS patients suffered from a premature thymic involution. However, several biological parameters could complicate the interpretation of TREC data. 21 TREC numbers can also be diluted by peripheral T cell proliferation. Chronic T cell stimulation induces an increased T cell turnover in RA patients, as evidenced by age-inappropriate short T cell telomere lengths in RA patients. 22 In addition, a decreased thymic output will induce compensatory auto-proliferation, a process which will also add to TREC dilution. An ageinappropriate thymic involution and an increased peripheral T cell turnover will both contribute to the decreased TREC numbers observed in RA patients. These findings are in 7 agreement with the results of other reports that described decreased TREC numbers in RA and MS patients. 3, 22, 23 In addition, we observed age-inappropriate high percentages of CD4+CD28 null T cells in RA and MS patients. Although CD4+CD28 null T cells are devoid of a major costimulatory signal, they are neither anergic nor functionally paralyzed. 2 They have gained proinflammatory capacities and cytotoxic function and are resistant to apoptosis. 5, 24 The presence of these cells early in disease and the fact that there is no correlation with disease duration suggests that CD4+CD28 null T cells are not just a marker for T cell aging but may be actively involved in the pathogenic process of AIDs. Our data are in line with the findings of other research groups that reported on increased percentages of CD4+CD28 null T cells in RA and MS patients. 2, 5, 6, [24] [25] [26] Besides thymic involution, several other mechanisms could have contributed to the ageinappropriate high frequencies of CD4+CD28 null T cells. A viral infection can cause massive proliferation of peripheral T cells. Normally, the majority of these newly generated effector cells are deleted at the end of the response, thereby restoring total T cell numbers to normal levels. However, defects in these deletion mechanisms can account for several immune abnormalities including a contracted TCR diversity and the accumulation of large numbers of clonally expanded T cells. These T cells can persist for many years and compromise immune competence. Several research groups claim that the CD4+CD28 null T cells which emerge in the elderly are indeed cytomegalovirus (CMV) specific cells. 27, 28 However, the TCR specificity of the CD4+CD28 null T cells in RA and MS patients has yet to be determined.
The decline in immunocompetence with age is accompanied by a steadily increasing incidence rate of AIDs. 29 A reduced thymic output will induce compensatory autoproliferation. This process can lead to a premature senescence of T cells and contribute to the immune abnormalities associated with autoimmunity and aging. Although the incidence of 8 AIDs increases with advancing age, immunosenescence is clearly not sufficient to induce autoimmunity. This illustrates that autoimmunity is a complex multifactorial disorder.
Premature aging could be a risk factor for developing autoimmunity in genetically prone individuals in a susceptible environment.
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